Dll4-Notch signaling as a therapeutic target in tumor angiogenesis

Tumor angiogenesis is an important target for cancer therapy, with most current therapies designed to block the VEGF signaling pathway. However, clinical resistance to anti-VEGF therapy highlights the need for targeting additional tumor angiogenesis signaling pathways. The endothelial Notch ligand D...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuhnert, Frank, Kirshner, Jessica R, Thurston, Gavin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195111/
https://www.ncbi.nlm.nih.gov/pubmed/21923938
http://dx.doi.org/10.1186/2045-824X-3-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195111/
https://www.ncbi.nlm.nih.gov/pubmed/21923938
http://dx.doi.org/10.1186/2045-824X-3-20

Ejemplares similares